You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) 3-HEXEN-1-OL


✉ Email this page to a colleague

« Back to Dashboard


3-HEXEN-1-OL Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for 3-Hexen-1-ol

Introduction

3-Hexen-1-ol, also known as cis-3-hexenol or trans-3-hexenol, is a fragrance and flavoring agent that has seen significant growth in various industries, including pharmaceuticals, although it is not typically classified as a pharmaceutical excipient. However, its applications and market dynamics can provide insights into its broader industrial relevance.

Chemical and Physical Properties

3-Hexen-1-ol is a clear, oily liquid with a strong fresh grass smell. It has a molecular formula of C₆H₁₂O and a molecular weight of 100.16 g/mol. Its physical properties include a boiling point of 165.73 °C, a flash point of 54 °C, and a log KOW of 1.61[1].

Market Size and Forecast

The global 3-hexen-1-ol market, while not specifically focused on pharmaceutical excipients, provides a broader context for its financial trajectory. As of 2023, the global 3-hexen-1-ol market was valued at USD 96.35 million and is projected to reach USD 114.53 million by 2030, growing at a CAGR of 2.5% from 2024 to 2030[2].

Applications and Segmentation

3-Hexen-1-ol is primarily used in the flavor and fragrance industries. Here are the key segments:

Flavor and Fragrance

  • It is used in food flavoring, particularly in mint-based products, and in household goods such as cleaning agents and personal care products[2][3].

Regional Analysis

  • The market is dominated by North America, driven by the rising demand from the food and beverage industry. Other significant regions include Europe, Asia-Pacific, Latin America, the Middle East, and Africa[2][3].

Market Drivers

Several factors drive the growth of the 3-hexen-1-ol market:

Increasing Demand for Flavor and Fragrance

  • The growing demand for natural and high-quality flavorings and fragrances in the food, beverage, and personal care industries is a key driver[2][3].

Technological Advancements

  • While not directly related to pharmaceutical excipients, advancements in purification and synthesis techniques can improve the quality and availability of 3-hexen-1-ol, indirectly benefiting related markets[2].

COVID-19 Impact

  • The COVID-19 pandemic saw higher-than-expected demand for 3-hexen-1-ol across all regions, which is expected to normalize post-pandemic but still contribute to steady growth[2].

Market Restraints and Challenges

Despite the growth, there are several challenges:

Regulatory Compliance

  • Compliance with safety and environmental regulations can be a challenge. For instance, 3-hexen-1-ol must meet safety standards set by bodies like the Expert Panel for Fragrance Safety[1].

Entry Barriers

  • The high entry barriers in the industry, including stringent regulatory requirements and the need for advanced technology, can limit new entrants[2].

Competitive Landscape

The market for 3-hexen-1-ol is competitive with several key players:

Major Players

  • Companies like ZEON (Japan), NHU (China), ShinEtsu (Japan), IFF (U.S.), Firmenich (Switzerland), and Sharp Mint (India) are major players in the industry[2].

Competitive Strategies

  • These companies engage in product benchmarking, competitive pricing, and strategic partnerships to maintain market share and drive innovation[2].

Safety and Toxicity

While 3-hexen-1-ol is not typically used as a pharmaceutical excipient, its safety profile is crucial for all applications:

Toxicity Studies

  • Studies have shown that 3-hexen-1-ol is not genotoxic, does not have skin sensitization potential, and has a high NOAEL (No Observed Adverse Effect Level) for systemic toxicity[1].

Environmental Safety

  • The compound has been evaluated for environmental safety, with data indicating it does not pose significant environmental risks[1].

Financial Trajectory

The financial trajectory of the 3-hexen-1-ol market is characterized by steady growth:

Revenue Growth

  • The market is expected to grow from USD 96.35 million in 2023 to USD 114.53 million by 2030, with a CAGR of 2.5%[2].

Regional Contributions

  • North America is expected to continue dominating the market, with significant contributions from Europe and Asia-Pacific[2][3].

Key Takeaways

  • Market Growth: The 3-hexen-1-ol market is projected to grow at a CAGR of 2.5% from 2024 to 2030.
  • Applications: Primarily used in flavor and fragrance industries.
  • Regional Dominance: North America leads the market, followed by Europe and Asia-Pacific.
  • Safety Profile: The compound is non-genotoxic and has a high NOAEL for systemic toxicity.
  • Competitive Landscape: High entry barriers and competitive strategies among major players.

FAQs

Q: What is the primary use of 3-hexen-1-ol? A: 3-Hexen-1-ol is primarily used in the flavor and fragrance industries, particularly in food flavoring and household goods.

Q: What is the projected market size of 3-hexen-1-ol by 2030? A: The global 3-hexen-1-ol market is projected to reach USD 114.53 million by 2030.

Q: Which region dominates the 3-hexen-1-ol market? A: North America dominates the 3-hexen-1-ol market, driven by the rising demand from the food and beverage industry.

Q: Is 3-hexen-1-ol safe for use? A: Studies have shown that 3-hexen-1-ol is not genotoxic, does not have skin sensitization potential, and has a high NOAEL for systemic toxicity.

Q: Who are the major players in the 3-hexen-1-ol market? A: Major players include ZEON (Japan), NHU (China), ShinEtsu (Japan), IFF (U.S.), Firmenich (Switzerland), and Sharp Mint (India).

Sources

  1. RIFM fragrance ingredient safety assessment, 3-hexen-1-ol (isomer unspecified)
  2. Virtu Market Research - 3-Hexen-1-ol Market | Size, Share, Growth | 2023 - 2030
  3. Market Research Intellect - Global Cis 3 Hexen 1 Ol Market Size And Forecast

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.